SEER
Seer Inc
NASDAQ: SEER · HEALTHCARE · BIOTECHNOLOGY
$1.88
-2.59% today
Updated 2026-04-29
Market cap
$106.07M
P/E ratio
—
P/S ratio
6.40x
EPS (TTM)
$-1.28
Dividend yield
—
52W range
$2 – $2
Volume
0.4M
Seer Inc (SEER) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.65M | $-13.07M | $-20.83M | $-46.35M | $-60.78M | $-59.06M | $-46.11M | $-44.45M |
| Capital expenditures | $168000.00 | $4.13M | $4.53M | $6.92M | $10.27M | $7.31M | $3.58M | $1.80M |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $672000.00 | $1.56M | $7.35M | $25.93M | $33.67M | $34.42M | $28.21M | $15.41M |
| Free cash flow | $-4.82M | $-17.20M | $-25.36M | $-53.27M | $-71.05M | $-66.37M | $-49.69M | $-46.24M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | $72.34M | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-100.59M | $-179.60M | — | — | — |